JPMORGAN CHASE & CO

Holdings History for Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM)

Symbol: IMNM on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$61,341,446	2,855,747	+2,823,144	+8659%	$21.48	Q4 2025
30 Sep 2025	0%	-0%	$381,781	32,603	-543,527	-94%	$11.71	Q3 2025
30 Jun 2025	0%	-0%	$5,358,009	576,130	-43,408	-7%	$9.30	Q2 2025
31 Mar 2025	0%	-0%	$4,169,490	619,538	-29,072		$6.73	Q1 2025
31 Dec 2024	0%	+0%	$6,888,239	648,610	+624,045	+2540%	$10.62	Q4 2024
30 Sep 2024	0%	+0%	$359,141	24,565	+1,520	+6.6%	$14.62	Q3 2024
30 Jun 2024	0%	+0%	$278,845	23,045	+22,317	+3066%	$12.10	Q2 2024
31 Mar 2024	0%	-0%	$17,968	728	-17,574	-96%	$24.68	Q1 2024
31 Dec 2023	0%	+0%	$195,831	18,302	+18,302	NEW	$10.70	Q4 2023
30 Sep 2023		-0%	$0	0	-915	-100%	$23.41	Q3 2023
30 Jun 2023	0%	+0%	$7,238	915	+915	NEW	$7.91	Q2 2023
30 Sep 2021		-0%	$0	0	-768	-100%	$23.41	Q3 2021
30 Jun 2021	0%	-0%	$13,000	768	-5,089	-87%	$16.93	Q2 2021
31 Mar 2021	0%	+0%	$198,000	5,857	+126	+2.2%	$33.81	Q1 2021
31 Dec 2020	0%	+0%	$55,000	5,731	+5,731	NEW	$9.60	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.